Skip to Content

L350 (Desvenlafaxine succinate extended-release 100 mg (base))

Pill imprint L350 has been identified as Desvenlafaxine succinate extended-release 100 mg (base).

Desvenlafaxine is used in the treatment of major depressive disorder; depression; fibromyalgia; anxiety; bipolar disorder (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Desvenlafaxine 100 mg (base) is not a controlled substance under the Controlled Substance Act (CSA).

Desvenlafaxine succinate extended-release
Imprint:
L350
Strength:
100 mg (base)
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Serotonin-norepinephrine reuptake inhibitors
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Manufacturer:
Breckenridge Pharmaceutical, Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide